Therapeutic Effect of Artemether in an Experimental Model of Nephrosis

References

• JR Aceng, JS Byarugaba, and JK Tumwine. (2005). Rectal artemether versus intravenous quinine for the treatment of cerebral malaria in children in Uganda: Randomized clinical trial. BMJ 330:317–318.
   PubMedGoogle Scholar
• E Aldieri, D Atragene, L Bergandi, C Riganti, C Costamagna, A Bosia, and D Ghigo. (2003). Artemisinin inhibits inducible nitric oxide synthase and nuclear factor NF-kB activation. FEBS Lett 552:141–144.
   PubMed Web of Science ®Google Scholar
• RW Bousnes, and AA Taussky. (1945). The calorimetric determination of creatinine by the Jaffe reaction. J Biol Chem 158:581–591.
   Web of Science ®Google Scholar
• C Bustos, S Gonzales-Cuadrado, M Ruiz-Ortega, C Gomes-Guerrero, E Gonzalez, JJ Plaza, and J Egido. (1995). Cyclosporin A (CsA) modulates the glomerular production of inflammatory mediators and proteoglycans in experimental nephrosis. Clin Exp Immunol 102:608–613.
   PubMedGoogle Scholar
• AR Butler, and YL Wu. (1992). Artemisinin (qinghaosu)—a new type of antimalarial drug. Chem Soc Rev 21:85–90.
   Web of Science ®Google Scholar
• HH Chen, HJ Zhou, and X Fang. (2003). Inhibition of human cancer cell line growth and human umbilical vein endothelial cell angiogenesis by artemisinin derivatives in vitro. Pharmacol Res 48:231–236.
   PubMed Web of Science ®Google Scholar
• R Cunard, and CJ Kelly. (2003). Immune-mediated renal disease. J Allergy Clin Immunol 111:637–643.
   Google Scholar
• PR Deepa, and P Varalakshmi. (2006). Influence of a low-molecular-weight heparin derivative on the nitric oxide levels and apoptotic DNA damage in adriamycin-induced cardiac and renal toxicity. Toxicology 217:176–183.
   Google Scholar
• PJ De Vries, and TK Dien. (1996). Clinical pharmacology and therapeutic potential of artemisinin and its derivatives in the treatment of malaria. Drugs 52:818–836.
   PubMed Web of Science ®Google Scholar
• BT Doumas, WA Watson, and HG Biggs. (1971). Albumin standards and the measurement of serum albumin with bromcresol green. Clin Chem Acta 31:87–88.
   PubMed Web of Science ®Google Scholar
• T Efferth. (2005). Mechanistic perspectives for 1,2,4-trioxanes in anti-cancer therapy. Drug Resist Updat 8:85–87.
   PubMed Web of Science ®Google Scholar
• T Efferth, M Marschall, X Wang, SM Huong, I Hauber, and A Olbrich. (2002a). Antiviral activity of artesunate towards wild-type, recombinant, and ganciclovir-resistant humancytomegaloviruses. J Mol Med 80:233–242.
   PubMed Web of Science ®Google Scholar
• T Efferth, A Olbrich, and R Bauer. (2002b). mRNA expression profiles for the response of human tumor cell lines to the antimalarial drugs artesunate, arteether, and artemether. Biochem Pharmacol 64:617–623.
   PubMed Web of Science ®Google Scholar
• C Falade, M Makanga, Z Premji, CE Ortmann, M Stockmeyer, and PI de Palacios. (2005). Efficacy and safety of artemether-lumefantrine (Coartem) tablets (six-dose regimen) in African infants and children with acute, uncomplicated falciparum malaria. Trans R Soc Trop Med Hyg 99:459–467.
   PubMed Web of Science ®Google Scholar
• JP Guthmann, S Cohuet, C Rigutto, F Fortes, N Saraiva, J Kiguli, J Kyomuhendo, M Francis, F Noel, M Mulemba, and S Balkan. (2006). High efficacy of two artemisinin-based combinations (artesunate + amodiaquine and artemether + lumefantrine) in Caala, Central Angola. Am J Trop Med Hyg 75:143–145.
   PubMedGoogle Scholar
• RK Haynes. (2006). From artemisinin to new artemisinin antimalarials: Biosynthesis, extraction, old and new derivatives, stereochemistry and medicinal chemistry requirements. Curr Top Med Chem 6:509–537.
   PubMed Web of Science ®Google Scholar
• RK Haynes, HW Chan, WY Ho, CK Ko, L Gerena, DE Kyle, W Peters, and BL Robinson. (2005). Convenient access both to highly antimalaria-active 10-arylaminoartemisinins, and to 10-alkyl ethers including artemether, arteether, and artelinate. Chembiochem 6:659–667.
   PubMed Web of Science ®Google Scholar
• XL He, and Z Liu. (2004). Protection of artesunate on activation and injury of vascular endothelial cells induced by lipopolysaccharide. Zhongguo Zhong Xi Yi Jie He Za Zhi 24:1110–1113.
   PubMedGoogle Scholar
• S Klahr, and J Morrissey. (2004). l-Arginine as a therapeutic tool in kidney disease. Semin Nephrol 24:389–394.
   Google Scholar
• DL Klayman. (1985). Qinghaosu (artemisinin): An antimalarial drug from China. Science 228:1049–1055.
   PubMed Web of Science ®Google Scholar
• D Kwiatkowski, and C Bate. (1995). Inhibition of tumour necrosis factor (TNF) production by antimalarial drugs used in cerebral malaria. Trans R Soc Trop Med Hyg 89:215–216.
   PubMed Web of Science ®Google Scholar
• G Lama, I Luongo, G Tirino, A Borriello, C Carangio, and ME Salsano. (2002). T-lymphocyte populations and cytokines in childhood nephrotic syndrome. Am J Kidney Dis 39:958–965.
   PubMed Web of Science ®Google Scholar
• MR Mahmoud, and SS Botros. (2005). Artemether as adjuvant therapy to praziquantel in murine Egyptian Schistosomiasis mansoni. J Parasitol 91:175–178.
   PubMed Web of Science ®Google Scholar
• M Makanga, Z Premji, C Falade, J Karbwang, EA Mueller, K Andriano, P Hunt, and PI De Palacios. (2006). Efficacy and safety of the six-dose regimen of artemether-lumefantrine in pediatrics with uncomplicated Plasmodium falciparum malaria: A pooled analysis of individual patient data. Am J Trop Med Hyg 74:991–998.
   PubMed Web of Science ®Google Scholar
• M Meremikwu, A Alaribe, R Ejemot, A Oyo-Ita, J Ekenjoku, C Nwachukwu, D Ordu, and E Ezedinachi. (2006). Artemether-lumefantrine versus artesunate plus amodiaquine for treating uncomplicated childhood malaria in Nigeria: Randomized controlled trial. Malaria J 5:44–45.
   Google Scholar
• T Okasora, T Takikawa, and Y Utsunomiya. (1992). Suppressive effect of superoxide dismutase on adriamycin nephropathy. Nephron 60:199–203.
   PubMed Web of Science ®Google Scholar
• AA Omari, C Gamble, and P Garner. (2006). Artemether-lumefantrine (four-dose regimen) for treating uncomplicated falciparum malaria. Cochrane Database Syst Rev 2: CD005965
   Google Scholar
• S Ozen, Y Usta, I Sahin-Erdemli, D Orhan, B Gumusel, B Yang, Y Gursoy, O Tulunay, T Dalkara, A Bakkaloglu, and M El-Nahas. (2001). Association of nitric oxide production and apoptosis in a model of experimental nephropathy. Nephrol Dial Transplant 16:32–38.
   PubMed Web of Science ®Google Scholar
• I Pesek-Diamond, G Ding, J Frye, and JR Diamond. (1992). Macrophages mediate adverse effects of cholesterol feeding in experimental nephrosis. Am J Physiol 263:776–783.
   Google Scholar
• R Price, M van Vugt, F Nosten, C Luxemburger, A Brockman, L Phaipun, T Chongsuphajaisiddhi, and N White. (1998). Artesunate versus artemether for the treatment of recrudescent multidrug-resistant falciparum malaria. Am J Trop Med Hyg 59:883–888.
   PubMed Web of Science ®Google Scholar
• G Remuzzi, C Zoja, and A Remuzzi. (1985). Low-protein diet prevents glomerular damage in adriamycin-treated rats. Kidney Int 28:21–27.
   PubMedGoogle Scholar
• IR Ribeiro, and P Olliaro. (1998). Safety of artemisinin and its derivatives. A review of published and unpublished clinical trials. Med Trop 58:50–53.
   PubMedGoogle Scholar
• WJ Shen, and M Thiero. (2005). Effects of combined artemether and dihydroartemisinin in treatment of children with falciparum malaria. Zhonghua Er Ke Za Zhi 43:65–66.
   PubMedGoogle Scholar
• H Shimoyama, M Nakajima, H Naka, Y Maruhashi, H Akazawa, T Ueda, M Nishiguchi, Y Yamoto, H Kamitsuji, and A Yoshioka. (2004). Up-regulation of interleukin-2 mRNA in children with idiopathic nephrotic syndrome. Pediatr Nephrol 19:1115–1121.
   PubMed Web of Science ®Google Scholar
• XZ Sun. (1991). Experimental study on the immunosuppressive effects of qinghaosu and its derivative. Zhong Xi Yi Jie He Za Zhi 11:37–38.
   PubMedGoogle Scholar
• CJ Sutherland, R Ord, S Dunyo, M Jawara, CJ Drakeley, N Alexander, R Coleman, M Pinder, G Walraven, and GA Targett. (2005). Reduction of malaria transmission to anopheles mosquitoes with a six-dose regimen of co-artemether. PloS Med 2:92–93.
   PubMed Web of Science ®Google Scholar
• RX Tan, WF Zheng, and HQ Tang. (1998). Biologically active substances from the genus Artemisia. Planta Med 64:295–302.
   PubMed Web of Science ®Google Scholar
• Y Usta, UB Ismailoglu, A Bakkaloglu, D Orhan, N Besbas, I Sahin-Erdemli, and S Ozen. (2004). Effects of pentoxifylline in adriamycin-induced renal disease in rats. Pediatr Nephrol 19:840–843.
   PubMed Web of Science ®Google Scholar
• H Van der Meersch. (2005). Review of the use of artemisinin and its derivatives in the treatment of malaria. J Pharm Belg 60:23–29.
   PubMedGoogle Scholar
• ND Vaziri, and KH Liang. (1996). Down-regulation of hepatic LDL receptor expression in experimental nephrosis. Kidney Int 50:887–893.
   PubMedGoogle Scholar
• MP Veniamin, and C Vakirtzi-Lemonias. (1970). Chemical basis of the carbamidodiacetyl micromethod for estimation of urea, citrulline and carbamyl derivatives. Clin Chem 16:3–6.
   PubMedGoogle Scholar
• M Wartenberg, S Wolf, P Budde, F Grunheck, H Acker, J Hescheler, G Wartenberg, and H Sauer. (2003). The antimalaria agent artemisinin exerts antiangiogenic effects in mouse embryonic stem cell-derived embryoid bodies. Lab Invest 83:1647–1655.
   PubMed Web of Science ®Google Scholar
• A Wasilewska, and W Zoch-Zwierz. (2006). Glucocorticoid receptor and vascular endothelial growth factor in nephrotic syndrome. Acta Paediatr 95:587–593.
   Google Scholar
• A Wasilewska, W Zoch-Zwierz, and E Tenderenda. (2006). Vascular endothelial growth factor in children with nephrotic syndrome treated with cyclosporine A. Acta Paediatr 95:291–296.
   Google Scholar
• GD Wu, HJ Zhou, and XH Wu. (2004). Apoptosis of human umbilical vein endothelial cells induced by artesunate. Vascul Pharmacol 41:205–212.
   PubMed Web of Science ®Google Scholar
• J Zachwieja, W Bobkowski, A Dobrowolska-Zachwieja, M Lewandowska-Stachowiak, M Zaniew, and J Maciejewski. (2002). Intracellular cytokines of peripheral blood lymphocytes in nephrotic syndrome. Pediatr Nephrol 17:733–740.
   Google Scholar
• J Zachwieja, W Bobkowski, M Zaniew, D Runowski, M Lewandowska-Stachowiak, and J Maciejewski. (2003). Intracellular synthesis of cytokines as the index of function of peripheral blood lymphocytes and monocytes in children with first relapse of nephrotic syndrome. Pol Merkuriusz Lek 14:289–294.
   Google Scholar
• Z Zhu, Y Wang, H Wang, and A Deng. (2001). The study on the relationship between serum vascular endothelial growth factor and proteinuria in adriamycin-induced nephrotic rats. J Tongji Med Univ 21:301–303.
   Google Scholar
• T Zima, V Tesar, J Crkovska, A Stejskalova, J Platenik, J Teminova, K Nemecek, M Janebova, and S Stipek. (1998). ICRF-187 (dexrazoxan) protects from adriamycin-induced nephrotic syndrome in rats. Nephrol Dial Transplant 13:1975–1979.
   PubMed Web of Science ®Google Scholar